BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 22356319)

  • 1. Inhibition of galactosyltransferases by a novel class of donor analogues.
    Descroix K; Pesnot T; Yoshimura Y; Gehrke SS; Wakarchuk W; Palcic MM; Wagner GK
    J Med Chem; 2012 Mar; 55(5):2015-24. PubMed ID: 22356319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel fluorescent probe for retaining galactosyltransferases.
    Pesnot T; Palcic MM; Wagner GK
    Chembiochem; 2010 Jul; 11(10):1392-8. PubMed ID: 20533489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The first C-glycosidic analogue of a novel galactosyltransferase inhibitor.
    Descroix K; Wagner GK
    Org Biomol Chem; 2011 Mar; 9(6):1855-63. PubMed ID: 21267505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of the retaining galactosyltransferase LgtC from Neisseria meningitidis in complex with donor and acceptor sugar analogs.
    Persson K; Ly HD; Dieckelmann M; Wakarchuk WW; Withers SG; Strynadka NC
    Nat Struct Biol; 2001 Feb; 8(2):166-75. PubMed ID: 11175908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific inhibition of an alpha-galactosyltransferase from Trypanosoma brucei by synthetic substrate analogues.
    Kolb V; Amann F; Schmidt RR; Duszenko M
    Glycoconj J; 1999 Sep; 16(9):537-44. PubMed ID: 10815990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective inhibition of beta-1,4- and alpha-1,3-galactosyltransferases: donor sugar-nucleotide based approach.
    Takayama S; Chung SJ; Igarashi Y; Ichikawa Y; Sepp A; Lechler RI; Wu J; Hayashi T; Siuzdak G; Wong CH
    Bioorg Med Chem; 1999 Feb; 7(2):401-9. PubMed ID: 10218835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sweet secrets of synthesis.
    Davies GJ
    Nat Struct Biol; 2001 Feb; 8(2):98-100. PubMed ID: 11175889
    [No Abstract]   [Full Text] [Related]  

  • 8. Structure of bovine alpha-1,3-galactosyltransferase and its complexes with UDP and DPGal inferred from molecular modeling.
    Rao M; Tvaroska I
    Proteins; 2001 Sep; 44(4):428-34. PubMed ID: 11484220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concise syntheses of selective inhibitors against α-1,3-galactosyltransferase.
    Zhang GL; Zhang LH; Ye XS
    Org Biomol Chem; 2010 Nov; 8(22):5062-8. PubMed ID: 20820649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thiosugar nucleotide analogs: synthesis of 5'-(2,3,4-tri-O-acetyl-6-S-acetyl-6-thio-alpha-D-galactopyranosyl diphosphate).
    Elhalabi J; Rice KG
    Carbohydr Res; 2002 Nov; 337(21-23):1935-40. PubMed ID: 12433459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. En route to deoxygenated N-acetyllactosamine analogues employing uridyl and galactosyl transferases.
    Lazarevic D; Streicher H; Thiem J
    Carbohydr Res; 2009 Aug; 344(12):1449-52. PubMed ID: 19560126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis of UDP-galactose binding by alpha-1,3-galactosyltransferase (alpha3GT): role of negative charge on aspartic acid 316 in structure and activity.
    Tumbale P; Jamaluddin H; Thiyagarajan N; Brew K; Acharya KR
    Biochemistry; 2008 Aug; 47(33):8711-8. PubMed ID: 18651752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of 2-deoxy-hexopyranosyl derivatives of uridine as donor substrate analogues for glycosyltransferases.
    Wandzik I; Bieg T; Czaplicka M
    Bioorg Chem; 2009 Dec; 37(6):211-6. PubMed ID: 19765794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational design, synthesis, and characterization of novel inhibitors for human beta1,4-galactosyltransferase.
    Takaya K; Nagahori N; Kurogochi M; Furuike T; Miura N; Monde K; Lee YC; Nishimura S
    J Med Chem; 2005 Sep; 48(19):6054-65. PubMed ID: 16162007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformational changes induced by binding UDP-2F-galactose to alpha-1,3 galactosyltransferase- implications for catalysis.
    Jamaluddin H; Tumbale P; Withers SG; Acharya KR; Brew K
    J Mol Biol; 2007 Jun; 369(5):1270-81. PubMed ID: 17493636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One-step synthesis of novel glycosyltransferase inhibitors.
    Evitt A; Tedaldi LM; Wagner GK
    Chem Commun (Camb); 2012 Dec; 48(97):11856-8. PubMed ID: 23125983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two galactosyltransferases' selection of different binders from the same uridine-based dynamic combinatorial library.
    Valade A; Urban D; Beau JM
    J Comb Chem; 2007; 9(1):1-4. PubMed ID: 17206823
    [No Abstract]   [Full Text] [Related]  

  • 18. Target-assisted selection of galactosyltransferase binders from dynamic combinatorial libraries. An unexpected solution with restricted amounts of the enzyme.
    Valade A; Urban D; Beau JM
    Chembiochem; 2006 Jul; 7(7):1023-7. PubMed ID: 16715540
    [No Abstract]   [Full Text] [Related]  

  • 19. Crystal structure of beta1,4-galactosyltransferase complex with UDP-Gal reveals an oligosaccharide acceptor binding site.
    Ramakrishnan B; Balaji PV; Qasba PK
    J Mol Biol; 2002 Apr; 318(2):491-502. PubMed ID: 12051854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Covalent inhibitors of LgtC: A blueprint for the discovery of non-substrate-like inhibitors for bacterial glycosyltransferases.
    Xu Y; Smith R; Vivoli M; Ema M; Goos N; Gehrke S; Harmer NJ; Wagner GK
    Bioorg Med Chem; 2017 Jun; 25(12):3182-3194. PubMed ID: 28462843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.